Amytis is a research workflow platform founded by Eva Steele and her co-founder Freddy, both researchers who experienced first-hand how fragmented and inefficient scientific workflows can become. Built during their PhDs at the University of Edinburgh, Amytis began as an attempt to solve persistent problems around data management, collaboration, and disconnected research systems within life sciences. What started as a side project has since evolved into a growing startup focused on helping biotech R&D teams work more cohesively, with connected workflows, integrated analysis tools, and clearer visibility across projects and datasets.
Over the last year, Amytis has moved from concept to product development, releasing its first platform version and gaining more than 300 downloads shortly after launch. The company has since refined its focus toward biotech R&D environments, where managing increasingly complex research operations has become a growing challenge. Support through Techscaler, delivered by CodeBase, helped connect the team with funding opportunities, international exposure, and market insight, particularly through its Silicon Valley programme.
Amytis emerged directly from Eva Steele and Freddy’s experiences as researchers navigating fragmented scientific workflows during their PhDs at the University of Edinburgh. Across experiments, datasets, notes, and collaborations, they saw how easily valuable information became siloed, duplicated, or disconnected from wider research efforts.
The idea behind Amytis was to create a connected operating system for life science research: a workspace where datasets, workflows, analysis tools, and outputs remain linked and visible throughout the research process. As the company evolved, the founders recognised these same operational challenges existed at scale within biotech R&D teams, shaping Amytis’ growing focus on helping organisations manage increasingly complex research environments more effectively.
Before joining Techscaler, Amytis was already gaining momentum technically, but Eva and the team were navigating the difficult transition from academic research into commercial product development. Moving from theoretical problem-solving into founder-led execution required an entirely different mindset, one shaped by user behaviour, market realities, and constant iteration. The challenge was not only refining the product, but understanding how to position it within a growing biotech ecosystem while building credibility as first-time founders.
Techscaler helped expose the team to founder communities, funding opportunities, and practical insight that accelerated both their commercial thinking and strategic planning as they prepared Amytis for wider growth and international expansion.
Techscaler became an important catalyst during a formative stage of Amytis’ development. Shortly after joining the programme, Eva discovered Bethnal Green Ventures through a Techscaler newsletter connection, which ultimately led to match-funding support for the company’s Smart Scotland grant. Beyond funding access, Techscaler’s ecosystem exposed the founders to wider startup networks, practical founder conversations, and opportunities that helped sharpen Amytis’ commercial direction.
For Eva, one of the biggest shifts came through repeated connections with users, mentors, and startup operators who reinforced the importance of adapting quickly around real-world needs rather than theoretical perfection. That mindset became central to how Amytis evolved its product and positioning.
Techscaler’s Silicon Valley programme gave Eva direct access to the pace, expectations, and operational realities of international startup ecosystems. For an early-stage company transitioning from academic research into commercial biotech infrastructure, the experience provided valuable clarity around what scaling internationally would actually require.
Meetings with organisations including the Chan Zuckerberg Initiative’s San Francisco Biohub helped Amytis understand both the opportunity and the standard expected within major U.S. research environments. Conversations around security requirements, pilot structures, and enterprise readiness gave the team a clearer roadmap for future expansion into the American market.
Equally important was the broader perspective gained from founder interactions, investor conversations, and exposure to how ambitious technology companies position themselves globally. Techscaler helped Amytis move from abstract international ambition toward a much more practical and actionable growth strategy.
Since participating in Techscaler, Amytis has continued refining both its product and long-term market strategy. The company released its first platform publicly in January, achieving more than 300 downloads and validating early interest from researchers and biotech teams. More recently, Amytis launched a pro version featuring automated data analysis and processing capabilities, expanding the platform’s practical functionality for research environments.
The company is now preparing for its next stage of growth through a $600K pre-seed raise designed to support pilot projects with biotech companies across the UK. Those pilots will help strengthen product development, generate real-world use cases, and position Amytis for expansion into European and U.S. biotech markets over the coming years.
For Eva and the team, the ambition extends beyond workflow management alone. The long-term vision is to build infrastructure that enables more collaborative, connected, and effective life science research globally.
For Amytis, Techscaler provided practical access to the kinds of opportunities, networks, and founder insight that are often difficult to reach at an early stage. From funding connections to international market exposure, the programme helped them move faster while building greater confidence around long-term ambition.
Delivered by CodeBase on behalf of the Scottish Government, Techscaler continues to play a critical role in helping founders bridge the gap between technical expertise and scalable commercial growth. Amytis reflects what becomes possible when research-led founders are supported through founder-first ecosystems designed to connect talent, opportunity, and global ambition early.
.svg)
